← All stocks

Biogen

BIIB Net buying
CIK 0000875045 #69 in the set updated 19 Sep 2026
Bought (120 mo)
$94.09M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$40.52M
$4.50M on a plan · $15.21M straight out of an exercise
Sold at will
$20.81M
22 of 49 sales
Net
+$53.57M
+$73.28M against sales at will

By person

41 insiders · 76 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
DENNER ALEXANDER J
Director
$90.83M (11)
+$90.83M
658,099
0.4454%
$132.25M
+106.9%
DORSA CAROLINE
Director
$151.56K (1)
$8.66M (1) scheduled
−$8.51M
31,002
0.0210%
$6.23M
+81.1%
Clancy Paul J
Executive VP and CFO
$5.75M (2)
−$5.75M
10,813
0.0073%
$2.17M
−59.8%
Sandrock Alfred
Head of Research & Development
$5.67M (8)
−$5.67M
10,169
0.0069%
$2.04M
+17.6%
PANGIA ROBERT W
Director
$5.54M (3) scheduled
−$5.54M
20,632
0.0140%
$4.15M
+23.9%
ALEXANDER SUSAN H
EVP Chief Legal Officer
$5.21M (3)
−$5.21M
61,889
0.0419%
$12.44M
+94.4%
Vounatsos Michel
Chief Executive Officer
$2.77M (5)
+$2.77M
67,261
0.0455%
$13.52M
+12,421%
Gregory Ginger
EVP, Human Resources
$2.49M (2)
−$2.49M
22,359
0.0151%
$4.49M
+3,341%
SHERWIN STEPHEN A
Director
$2.03M (3) scheduled
−$2.03M
15,193
0.0103%
$3.05M
+236.9%
Singhal Priya
Head of Development
$2.02M (16) scheduled
−$2.02M
8,043
0.0054%
$1.62M
+327.6%
Guindo Chirfi
Head of Glob Prod Strat & Com
$1.36M (1)
−$1.36M
7,364
0.0050%
$1.48M
Posner Brian S
Director
$684.97K (3)
−$684.97K
8,175
0.0055%
$1.64M
+31.1%
Ehlers Michael D
EVP, Research and Development
$350.00K (1)
−$350.00K
8,025
0.0054%
$1.61M
+140.3%
Izzar Rachid
Head of Global Product Strat.
$300.11K (1) scheduled
−$300.11K
11,011
0.0075%
$2.21M
Mantas Jesus B
Director
$239.77K (1)
+$239.77K
11,263
0.0076%
$2.26M
Minor Lloyd
Director
$239.75K (2) scheduled
−$239.75K
2,689
0.0018%
$540.38K
Karaboutis Adriana
EVP, Tech, Bus. Sol & Corp Aff
$214.90K (3)
−$214.90K
8,752
0.0059%
$1.76M
+6.8%
Rowinsky Eric K
Director
$101.26K (1)
+$101.26K
25,844
0.0175%
$5.19M
+97.4%
Murphy Nicole
Head of Pharm Ops and Tech
$585.11 (1)
+$585.11
19,611
0.0133%
$3.94M
+1,067%
Viehbacher Christopher
President and CEO
29,924
0.0203%
$6.01M
+327.5%
McDonnell Michael R.
EVP, Chief Financial Officer
24,341
0.0165%
$4.89M
Mulligan Richard
Director
15,099
0.0102%
$3.03M
+68.3%
LEAMING NANCY
Director
13,763
0.0093%
$2.77M
+52.8%
Kramer Robin
Chief Financial Officer
11,472
0.0078%
$2.31M
+2,905%
HAWKINS WILLIAM A
Director
10,365
0.0070%
$2.08M
PAPADOPOULOS STELIOS
Director
10,095
0.0068%
$2.03M
SCHENK LYNN
Director
9,032
0.0061%
$1.82M
+51.2%
Freire Maria C
Director
8,820
0.0060%
$1.77M
McKenzie Paul
EVP Pharmaceutical Oper & Tech
7,235
0.0049%
$1.45M
+1,697%
DiPietro Kenneth
EVP Human Resources
7,177
0.0049%
$1.44M
+82.3%
LANGER SUSAN
Director
6,634
0.0045%
$1.33M
+1,345%
Keeney Adam
Head of Corporate Development
6,365
0.0043%
$1.28M
Patolawala Monish D
Director
5,215
0.0035%
$1.05M
Galdes Alphonse
EVP Pharmaceutical Oper & Tech
5,064
0.0034%
$1.02M
+213.3%
COVINO GREGORY F
VP, Chief Accounting Officer
4,744
0.0032%
$953.43K
+51.7%
Grogan Jane
Head of Research
4,058
0.0027%
$815.50K
Pangalos Menelas N
Director
3,875
0.0026%
$778.72K
CAPELLO JEFFREY D
EVP & Chief Financial Officer
3,118
0.0021%
$626.59K
JONES WILLIAM D /CA/
Director
2,145
0.0015%
$431.06K
Godbout Sean
Chief Accounting Officer
1,342
0.0009%
$269.62K
+181.5%
Karp Daniel
EVP, Corporate Development
930
0.0006%
$186.97K
+636.1%
Insider
Date
Role
Action
Shares
Price
Amount
Minor Lloyd
4 Aug 2026
Director
Sold on a plan
593
$200.96
$119.17K
Minor Lloyd
3 Aug 2026
Director
Sold on a plan
593
$203.34
$120.58K
Singhal Priya
9 Feb 2026
Head of Development
Sold on a plan
2,660
$199.83
$531.55K
Singhal Priya
2 Feb 2026
Head of Development
Sold on a plan
748
$179.30
$134.12K
Singhal Priya
2 Sep 2025
Head of Development
Sold on a plan
517
$133.55
$69.05K
Izzar Rachid
8 Jul 2025
Head of Global Product Strat.
Sold on a plan
2,223
$135.00
$300.11K
Singhal Priya
19 May 2025
Head of Development
Sold on a plan
3,806
$126.25
$480.51K
SHERWIN STEPHEN A
7 Mar 2025
Director
Sold on a plan
8,760
$150.02
$1.31M
Singhal Priya
9 Dec 2024
Head of Development
Sold on a plan
110
$157.21
$17.29K
Singhal Priya
3 Sep 2024
Head of Development
Sold on a plan
431
$204.22
$88.02K
Singhal Priya
2 Apr 2024
Head of Development
Sold on a plan
93
$213.09
$19.82K
Singhal Priya
22 Feb 2024
Head of Development
Sold on a plan
262
$221.23
$57.96K
Singhal Priya
12 Feb 2024
Head of Development
Sold on a plan
419
$239.45
$100.33K
Singhal Priya
2 Feb 2024
Head of Development
Sold on a plan
634
$245.93
$155.92K
Singhal Priya
11 Dec 2023
Head of Development
Sold on a plan
110
$248.00
$27.28K
Singhal Priya
5 Sep 2023
Head of Development
Sold on a plan
431
$269.43
$116.12K
Singhal Priya
3 Jul 2023
Head of Development
Sold on a plan
81
$282.87
$22.91K
Gregory Ginger
28 Apr 2023
EVP, Human Resources
Sold on a plan
2,681
$300.00
$804.30K
Singhal Priya
4 Apr 2023
Head of Development
Sold on a plan
91
$277.11
$25.22K

What was left out

Form 4 filings counted 437
Amendments (4/A) skipped 1
Filings about a different issuer 9
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 19
Sales straight out of an exercise 8
Sales at will 22
Transactions with no price 0
Shares from compensation/vesting 969,482
Sales filed before the plan box existed 21
History held since 26 Sep 2016